Catalyst Brief

← Calendar

Readoutin 14d

Guangdong Hengrui Pharmaceutical Co., Ltd — SHR-1819 Injection

Phase 3 primary completion: A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis.

Date
Dec 2026
Type
Readout
Indication
Seasonal Allergic Rhinitis

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.